Precursor Condition
High Grade Cervical Intraepithelial Neoplasia
CI-CAN-00002873Explore in graph →
Precursor14 active trials
- NCIt
- C7670
Loading cancer entity…
Precursor Condition
CI-CAN-00002873Explore in graph →
Clinical trials
50 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02529930 | An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3) | completed | Phase 1 / Phase 2 | 34 | Nykode Therapeutics ASAINDUSTRY | 1 | Jul 13, 2022 | clinicaltrials |
| NCT00081263 | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia | completed | Phase 2 | 130 | Gynecologic Oncology GroupNETWORK | 1 | Sep 15, 2017 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jul 13, 2022source: clinicaltrials